Macrophage migration inhibitory factor (MIF) secreted by CSCs inhibits anti-cancer immune responses via the CXCR2 pathway, increasing MDSC arginase-1 (ARG-1) expression and inhibiting CD8+T cell migration [67]. The gene discussed is CXCR2; the disease is cancer.